Pediatric Virtual Lupus Clinic: All Cases
PVLC-ALL-EXP2027
Lupus, Pediatric
Monday, December 2, 2024, 1:00 AM
Wednesday, December 1, 2027, 11:55 PM
CME, ABIM MOC, ABP MOC
Advanced Practice Nurses, Primary Care Providers, Physician Assistants
Virtual Lupus Clinic
1.50
1.50
1.50

Activity Overview

The Pediatric Virtual Lupus Clinic is a two-part series with case-based learning to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine two patients, each presenting with different symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.

  • Case 1 is a 13-year-old Black female with fatigue and joint pain.
  • Case 2 is a 14-year-old Hispanic male with fatigue, facial swelling, and intermittent chest pain.


Pediatric Virtual Lupus Clinic Series

This activity is part of a series. See the other activities in the series below:

Registration is complimentary.


Target Audience

Primary care providers, advanced practice nurses, physician assistants.


Learning Objectives

Upon completion of this activity, participants should be able to:

Case 1

  • Identify when lupus should be suspected
  • Use appropriate baseline labs and recognize when an ANA is appropriate
  • Describe different skin findings and how differences in skin tones can affect the way a rash looks
  • Implement co-management and referral triaging for a patient

Case 2

  • Identify when lupus should be suspected
  • Identify lupus signs and symptoms and when to suspect renal disease
  • Examine a differential diagnosis for individuals presenting with a combination of renal and pulmonary disease


CE & MOC Information

CME

ACCME Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.


AMA Designation Statement

The American College of Rheumatology designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by December 1, 2027, at 11:59 PM ET.


MOC

MOC Recognition Statement: American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

CME Logo

MOC Recognition Statement: American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by December 1, 2027, at 11:59 PM ET.


Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness
  7. Independent contractor
  8. Executive role and/or ownership interest
  9. Royalties and/or patent beneficiary
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Private investigator
  13. Expert witness
  14. Equity interest
  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.


Planning Committee

The following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.

  • Emily F. Beil, MD
  • Anita Dhanrajani, MBBS, MSc
  • Marla Guzman, MD
  •  Joseph McDonald, MD, MS, RhMSUS
  • Michael Bradley Nelson, MD, MPH
  • Jessica Perfetto, MD
  • Heather Walters, MD


Reviewers

The following reviewers have no relevant financial relationship(s) with ineligible companies to disclose.

  • Sheira Neely, APRN, CPNP
  • Carolyn Zic, APRN, FNP-BC


Acknowledgement of Commercial Support

This activity is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award of $7 million with 100 percent funded by CDC/HHS. The activity content was provided by the author(s) and does not necessarily represent the official views of, nor an endorsement by, the CDC/HHS or U.S. Government.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.

Pediatric Virtual Lupus Clinic - Case 1

The Pediatric Virtual Lupus Clinic is a two-part series with case-based learning to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine two patients, each presenting with different symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.

Pediatric Virtual Lupus Clinic - Case 2

The Pediatric Virtual Lupus Clinic is a two-part series with case-based learning to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine two patients, each presenting with different symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.